Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Puthumana

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
JAMA Network Open|January 16, 2019
Availability of Investigational Medicines Through the US Food and Drug Administration's Expanded Access and Compassionate Use ProgramsJeremy Puthumana, Jennifer E Miller, Jeanie Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2013
Kelch-like 3 and Cullin 3 regulate electrolyte homeostasis via ubiquitination and degradation of WNK4Shigeru Shibata, Junhui Zhang, Jeremy Puthumana, et al.
BMC Nephrology|February 22, 2017
Biomarkers for the detection of renal fibrosis and prediction of renal outcomes: a systematic reviewSherry G Mansour, Jeremy Puthumana, Steven G Coca, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 26, 2016
Urine Interleukin 18 and Lipocalin 2 Are Biomarkers of Acute Tubular Necrosis in Patients With Cirrhosis: A Systematic Review and Meta-analysisJeremy Puthumana, Xavier Ariza, Justin M Belcher, et al.
JAMA Network Open|June 10, 2021
Characteristics of Clinical Studies Used for US Food and Drug Administration Supplemental Indication Approvals of Drugs and Biologics, 2017 to 2019Meera Dhodapkar, Audrey D Zhang, Jeremy Puthumana, et al.
JAMA Network Open|April 22, 2020
Assessment of Clinical Trials Supporting US Food and Drug Administration Approval of Novel Therapeutic Agents, 1995-2017Audrey D Zhang, Jeremy Puthumana, Nicholas S Downing, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 27, 2026
Biomarkers of inflammation and risk of adverse events in patients with cirrhosisJeremy Puthumana, Justin M Belcher, Guadalupe Garcia-Tsao, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 2014
Angiotensin II signaling via protein kinase C phosphorylates Kelch-like 3, preventing WNK4 degradationShigeru Shibata, Juan Pablo Arroyo, María Castañeda-Bueno, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2017
Phosphorylation by PKC and PKA regulate the kinase activity and downstream signaling of WNK4Maria Castañeda-Bueno, Juan Pablo Arroyo, Junhui Zhang, et al.
Journal of the American Society of Nephrology : JASN|August 16, 2017
Relationship of Kidney Injury Biomarkers with Long-Term Cardiovascular Outcomes after Cardiac SurgeryChirag R Parikh, Jeremy Puthumana, Michael G Shlipak, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
JAMA Network Open|January 16, 2019
Availability of Investigational Medicines Through the US Food and Drug Administration's Expanded Access and Compassionate Use ProgramsJeremy Puthumana, Jennifer E Miller, Jeanie Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2013
Kelch-like 3 and Cullin 3 regulate electrolyte homeostasis via ubiquitination and degradation of WNK4Shigeru Shibata, Junhui Zhang, Jeremy Puthumana, et al.
BMC Nephrology|February 22, 2017
Biomarkers for the detection of renal fibrosis and prediction of renal outcomes: a systematic reviewSherry G Mansour, Jeremy Puthumana, Steven G Coca, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 26, 2016
Urine Interleukin 18 and Lipocalin 2 Are Biomarkers of Acute Tubular Necrosis in Patients With Cirrhosis: A Systematic Review and Meta-analysisJeremy Puthumana, Xavier Ariza, Justin M Belcher, et al.
JAMA Network Open|June 10, 2021
Characteristics of Clinical Studies Used for US Food and Drug Administration Supplemental Indication Approvals of Drugs and Biologics, 2017 to 2019Meera Dhodapkar, Audrey D Zhang, Jeremy Puthumana, et al.
JAMA Network Open|April 22, 2020
Assessment of Clinical Trials Supporting US Food and Drug Administration Approval of Novel Therapeutic Agents, 1995-2017Audrey D Zhang, Jeremy Puthumana, Nicholas S Downing, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 27, 2026
Biomarkers of inflammation and risk of adverse events in patients with cirrhosisJeremy Puthumana, Justin M Belcher, Guadalupe Garcia-Tsao, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 2014
Angiotensin II signaling via protein kinase C phosphorylates Kelch-like 3, preventing WNK4 degradationShigeru Shibata, Juan Pablo Arroyo, María Castañeda-Bueno, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2017
Phosphorylation by PKC and PKA regulate the kinase activity and downstream signaling of WNK4Maria Castañeda-Bueno, Juan Pablo Arroyo, Junhui Zhang, et al.
Journal of the American Society of Nephrology : JASN|August 16, 2017
Relationship of Kidney Injury Biomarkers with Long-Term Cardiovascular Outcomes after Cardiac SurgeryChirag R Parikh, Jeremy Puthumana, Michael G Shlipak, et al.
Pageof 2